Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5219950
Max Phase: Preclinical
Molecular Formula: C38H51BrO6
Molecular Weight: 683.72
Associated Items:
ID: ALA5219950
Max Phase: Preclinical
Molecular Formula: C38H51BrO6
Molecular Weight: 683.72
Associated Items:
Canonical SMILES: COc1ccc(/C=C2\C[C@]3(C)[C@H]4C(=O)C=C5[C@@H]6C[C@@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C(C)(C)[C@H]2O)c(Br)c1O
Standard InChI: InChI=1S/C38H51BrO6/c1-33(2)27-11-12-38(7)30(36(27,5)19-22(31(33)42)17-21-9-10-26(45-8)29(41)28(21)39)25(40)18-23-24-20-35(4,32(43)44)14-13-34(24,3)15-16-37(23,38)6/h9-10,17-18,24,27,30-31,41-42H,11-16,19-20H2,1-8H3,(H,43,44)/b22-17+/t24-,27-,30+,31-,34+,35-,36-,37+,38+/m0/s1
Standard InChI Key: XOBKKYMCGNONGP-SSOBHVIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 683.72 | Molecular Weight (Monoisotopic): 682.2869 | AlogP: 8.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.06 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.44 | CX Basic pKa: | CX LogP: 8.04 | CX LogD: 5.15 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.30 | Np Likeness Score: 2.33 |
1. Kumar A, Archo S, Singh CP, Naikoo SH, Singh B, Kaur S, Tasduq SA.. (2022) Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging., 76 [PMID:36167293] [10.1016/j.bmcl.2022.128984] |
Source(1):